Le Lézard
Classified in: Health
Subject: LEG

DaVita Celebrates Signing of the Colorado Living Donor Support Act


DENVER, May 18, 2018 /PRNewswire/ --

The following is attributable to DaVita Inc.

DaVita congratulates the American Transplant Foundation and the Colorado State Legislature for passing the Colorado Living Donor Support Act, which will provide crucial support to Coloradans willing to be living organ donors. Thousands of Colorado patients awaiting life-sustaining transplants will also benefit from this legislation once the bill goes into effect in 2020.

DaVita and its teammates know firsthand how much it means for a patient to receive a kidney donation. Every year, we support tens of thousands of patients on their transplant journey, including the search for a related or non-related living donor.

Despite the overwhelming need for organ donations, very few states offer living donor benefits. In passing and signing this bill, Colorado is setting an example for the rest of the country. Many living donors in Colorado will no longer have to worry about taking time off or potentially losing income or even their job as they recover from providing an incredible gift to another human being.

General Facts on Kidney Disease and Transplantation

How DaVita Supports Living Organ Donation & Transplantation

As a result, an average of 17 DaVita patients receive a kidney transplant every day, including many whose donation comes from a living donor. Also, DaVita recently launched the Transplant Waitlist Support Program, which proactively shares its waitlisted patients' health data with participating transplant centers to help keep information current and patients on the waitlist ready to receive a kidney.

To learn more about kidney disease or transplantation, visit DaVita.com/Transplants.

About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita Inc., a Fortune 500® company, that through its operating divisions provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of March 31, 2018, DaVita Kidney Care operated or provided administrative services at 2,539 outpatient dialysis centers located in the United States serving approximately 198,000 patients. The company also operated 241 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.

Contact Information
Media:
Ashley Henson
[email protected]
303-876-6626

DaVita logo. (PRNewsFoto/DaVita)

 

SOURCE DaVita


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: